PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Confronting pharma, Trump admin seeks price disclosure in drug ads

The Trump administration made one of its most aggressive moves yet to address rising drug costs, proposing to require drugmakers include list prices in direct-to-con...
Continue Reading →
News

Pharma Publications at CPhI Worldwide 2018

In the heart of the action of ICSE Pharma Insights Briefings The international pharmaceutical networking exhibition, CPhI Worldwide 2018, is being held at - IFEMA...
Continue Reading →
News

Spinraza® ▼ (nusinersen) Interim Data from Phase 2 Trial, NURTURE, Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy

At point of follow-up NURTURE all study participants were alive and did not require permanent ventilation, in contrast to natural history of spinal muscular atrophy...
Continue Reading →
News

CRUK forges £30m ‘post-Brexit’ R&D alliance

Cancer Research UK has joined forces with two peer organisations in Italy and Spain to fund half a dozen R&D projects – and to show that Brexit need not be ...
Continue Reading →
News

AstraZeneca chief on Brexit: “It’s going to be really painful”

AstraZeneca’s stockpiling of medicines ahead of Brexit is a temporary safeguard at best, and shortages could follow if no customs deal is agreed with the E...
Continue Reading →
News

Janssen secures NHS England funding for HIV therapy Symtuza

Janssen Pharmaceutical has announced funding from NHS England (NHSE) for Symtuza to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and ad...
Continue Reading →
News

US and Cuba form biotech joint venture to develop cancer drugs

US-Cuba JV will focus on development of oncology drugs. US and Cuba have formed a biotech joint venture, called Innovative Immunotherapy Alliance, focused on the...
Continue Reading →
News

Hong Kong researchers create tiny soft robot for drug delivery

Tiny, multi-leg robot can potentially deliver drugs within human body. Researchers at City University of Hong Kong have developed a tiny, soft robot to be used f...
Continue Reading →
News

The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation."

Cancer kills millions of people every year and is one of humanity's greatest health challenges. By stimulating the inherent ability of our immune system to attack tu...
Continue Reading →
News

GP closures could have ‘catastrophic’ effect on patient care, says RCGP

GP leaders are warning that more than 2.5 million patients across England could see their GP practice close in the next five years because of the high number of fami...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026